Moderna share price doubles on melanoma vaccine trial success
4 sources·Updated August 20, 2026
Moderna melanoma vaccine
Covered by 4 sources
- NYT Business·5h agoModerna’s Shift to Cancer Company Lifts Stock Up 177%
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
Read at NYT Business → - Geo News·1d agoModerna's promising cancer vaccine sends stock soaring: Here's what happened
Moderna's promising cancer vaccine sends stock soaring: Here's what happened The biotech firm Moderna’s stock price has risen sharply since the release of preliminary trial results for its experimental personalized cancer vaccine. This represents the first true test of the
Read at Geo News → - Financial Times·1d agoModerna share price doubles on melanoma vaccine trial success
Company’s melanoma cancer vaccine being developed with Merck
Read at Financial Times →
